Abstract
The growth of blood vessels (a process known as angiogenesis) is essential for organ growth and repair. An imbalance in this process contributes to numerous malignant, inflammatory, ischaemic, infectious and immune disorders. Recently, the first anti-angiogenic agents have been approved for the treatment of cancer and blindness. Angiogenesis research will probably change the face of medicine in the next decades, with more than 500 million people worldwide predicted to benefit from pro- or anti-angiogenesis treatments.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ny, A. et al. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nature Med. 11, 998–1004 (2005).
Carmeliet, P. Angiogenesis in health and disease. Nature Med. 9, 653–660 (2003).
Carmeliet, P. & Tessier-Lavigne, M. Common mechanisms of nerve and blood vessel wiring. Nature 436, 193–200 (2005).
Lambrechts, D., Storkebaum, E. & Carmeliet, P. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS? Trends Mol. Med. 10, 275–282 (2004).
Luttun, A., Autiero, M., Tjwa, M. & Carmeliet, P. Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets? Biochim. Biophys. Acta 1654, 79–94 (2004).
Simons, M. Angiogenesis: where do we stand now? Circulation 111, 1556–1566 (2005).
Jain, R. K., Duda, D. G., Clark, J. W. & Loeffler, J. S. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nature Clin. Pract. Oncol. (in the press).
Jain, R. K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58–62 (2005).
Kerbel, R. S. & Kamen, B. A. The anti-angiogenic basis of metronomic chemotherapy. Nature Rev. Cancer 4, 423–436 (2004).
Ostman, A. PDGF receptors—mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev. 15, 275–286 (2004).
Song, S., Ewald, A. J., Stallcup, W., Werb, Z. & Bergers, G. PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nature Cell Biol. 7, 870–879 (2005).
Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E. & Hanahan, D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111, 1287–1295 (2003).
Heldin, C. H., Rubin, K., Pietras, K. & Ostman, A. High interstitial fluid pressure — an obstacle in cancer therapy. Nature Rev. Cancer 4, 806–813 (2004).
Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005).
Buttery, R. C., Rintoul, R. C. & Sethi, T. Small cell lung cancer: the importance of the extracellular matrix. Int. J. Biochem. Cell Biol. 36, 1154–1160 (2004).
Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
De Palma, M. et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211–226(2005).
Takakura, N. et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell 102, 199–209 (2000).
Rafii, S. & Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nature Med. 9, 702–712 (2003).
Grunewald, M. et al. VEGF-induced adult neovascularization depends on SDF-1-mediated retention of bone marrow derived accessory cells. Cell (in the press).
Kaplan, R. N. et al. VEGFR1-positive hematopoietic bone marrow progenitors initiate the premestatic niche. Nature 438, 820–827 (2005).
Zou, W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Rev. Cancer 5, 263–274 (2005).
Izumi, Y., Xu, L., di Tomaso, E., Fukumura, D. & Jain, R. K. Tumour biology: Herceptin acts as an anti-angiogenic cocktail. Nature 416, 279–280 (2002).
Hirakawa, S. et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089–1099 (2005).
Fletcher, J. A. Role of KIT and platelet-derived growth factor receptors as oncoproteins. Semin. Oncol. 31, 4–11 (2004).
Gilbert, S. F. Developmental Biology, 6th edn (Swarthmore College, Sinauer Assoc., Sunderland, MA, 2000).
Hoyer, M. Untersuchungen ueber das Lymphgefaessystem der Froschlarven. Bull. Acad. Cracov. Teill II, 451–464 (1905).
Acknowledgements
The author regrets that, owing to space limitations, he has been unable to refer to all of the primary literature and had to rely instead, in many instances, on reviews. P.C. is supported by grants from FWO, the European Union and the Concerted Research Activities of Belgium.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare competing financial interests: Peter Carmeliet declares to be an inventor on intellectual property rights related to some anti-angiogenic agents of the VEGF family.
Additional information
Author information Reprints and permissions information is available at npg.nature.com/reprintsandpermissions.
Supplementary information
Supplementary information
(DOC 472 kb)
Rights and permissions
About this article
Cite this article
Carmeliet, P. Angiogenesis in life, disease and medicine. Nature 438, 932–936 (2005). https://doi.org/10.1038/nature04478
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature04478
This article is cited by
-
Role of cell rearrangement and related signaling pathways in the dynamic process of tip cell selection
Cell Communication and Signaling (2024)
-
A defined clathrin-mediated trafficking pathway regulates sFLT1/VEGFR1 secretion from endothelial cells
Angiogenesis (2024)
-
The Statistical Theory of the Angiogenesis Equations
Journal of Nonlinear Science (2024)
-
ETV2/ER71, the key factor leading the paths to vascular regeneration and angiogenic reprogramming
Stem Cell Research & Therapy (2023)
-
Sufficient Cav-1 levels in the endothelium are critical for the maintenance of the neurovascular unit in the retina
Molecular Medicine (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.